New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALOÂ and a Common Antiretroviral Therapy

MONTGOMERY Ala. and INDIANAPOLIS July 18 2011 PRNewswire Kowa Pharmaceuticals America Inc. and Eli Lilly and Company NYSE LLY today released new study results that investigated the potential interaction of cholesterol drug LIVALO pitavastatin 4 mg in heal...